R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

3D rendering of human intestine villi and microbiome

Understanding the microbiome as an ‘overlooked critical orga...

Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there is untapped potential in the area.

R&D

Achieving diversity, equity and inclusion in clinical trials

Making sure clinical trials are diverse and representative of the populations they’re studying isn’t just the right thing to do to promote inclusivity and equity; it’s also just good scienc

R&D

CRISPR therapies targeting the next breakthrough in oncology

The potential of CRISPR technology has been a hot topic in the industry ever since it was first developed, but as trials progress further into the clinic, what therapeutic areas could be se

R&D

Global communication network around planet Earth in space, worldwide exchange of information by internet and connected satellites for finance, cryptocurrency or IoT technology

Breaking into the global pharmaceutical market

In 2022, pharma is truly a global industry, and innovation can come from anywhere.

Patients

Study finds unexpected prescription influencers in healthcar...

Cate Evans, SVP group director, strategy at Havas Media Group, and Nick Lapolla, research director at MedSurvey tell us about a two-phase research study the companies recently performed to

R&D